Deciphera Pharmaceuticals, Inc. (DCPH)
After hours:
| Previous Close | 13.73 |
| Open | 13.79 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1100 |
| Day's Range | 13.22 - 13.95 |
| 52 Week Range | 6.51 - 37.99 |
| Volume | |
| Avg. Volume | 1,256,887 |
| Market Cap | 780.719M |
| Beta (5Y Monthly) | 1.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer
WALTHAM, Mass., June 16, 2022--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced the appointment of Kelley Dealhoy as Senior Vice President and Chief Business Officer. Ms. Dealhoy brings 20 years of life science leadership experience to the role, and her responsibilities will include developing and leading the Company’s business development efforts as well as supporting corporate strategy initiatives.
- Business Wire
Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences
WALTHAM, Mass., June 02, 2022--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that members of the management team will participate in fireside chats at the following investor conferences:
- Business Wire
Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results
WALTHAM, Mass., May 04, 2022--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced financial results for the first quarter ended March 31, 2022, and provided a corporate update.
